Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QiShenYiQi Dripping Pills after reperfusion for STEMI
ChiCTR-TRC-13003431Phase 4Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jan 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of qishen yiqi dripping pills in myocardial infarction (MI) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Left ventricular ejection fraction and Wall motion score index. Started Jan 2013; status: completed.
02
Drugs
qishen yiqi dripping pills
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-TRC-13003431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003431.